Concepedia
Statistics
Publications
2
Citations
27
H-Index
Active since
2011
W.Y. Tak is an author specializing in pharmacology, viral hepatitis treatment, and hepatocellular carcinoma treatment.
Publications per year
2011–2016
6576 POSTER Phase II Safety Study of the Oral Multikinase Inhibitor Regorafenib (BAY 73-4506) as Second-line Therapy in Patients With Hepatocellular Carcinoma
Luigi Bolondi, W.Y. Tak, Antonio Gasbarrini et al. · European Journal of Cancer · 2011 · 15 citations
Medicine, Oncology, Pharmacology +12
HBsAg Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2A in Chronic Hepatitis B: Long-Term Results of a Global Randomized Controlled Trial
S.H. Ahn, Patrick Marcellin, Xiao Ma et al. · Journal of Hepatology · 2016 · 12 citations
Pharmacy, Pharmacology, Pharmacotherapy +17
1–2 of 2